David H. Ilson
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,640 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology(2019)1,084 cited
- → Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology(2016)947 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 1.2015(2015)652 cited
- → Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial(2023)642 cited
- → Gastric Cancer, Version 2.2013(2013)514 cited